US Stock MarketDetailed Quotes
ABIO ARCA biopharma
- 3.490
- -0.060-1.69%
Close Jul 17 16:00 ET
- 3.500
- +0.010+0.29%
Post 18:44 ET
50.63MMarket Cap-8309P/E (TTM)
3.670High3.400Low90.43KVolume3.550Open3.550Pre Close314.66KTurnover1.85%Turnover RatioLossP/E (Static)14.51MShares4.49052wk High1.44P/B17.07MFloat Cap1.56052wk Low--Dividend TTM4.89MShs Float6327683.189Historical High--Div YieldTTM7.61%Amplitude1.560Historical Low3.479Avg Price1Lot Size
About ARCA biopharma Company
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Company Profile
SymbolABIO
Company NameARCA biopharma
Listing DateAug 8, 1997
Issue Price14.00
Founded1992
CEOMr. Thomas A. Keuer
MarketNASDAQ
Employees5
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10170 Church Ranch Way,Suite 100
CityWestminster
ProvinceColorado
CountryUnited States of America
Zip Code80021
Phone1-720-940-2100
Websitehttp://www.arcabio.com
Company Executives
- Name
- Position
- Salary
- Thomas A. Keuer
- Chief Operating Officer, President and Principal Executive Officer
- 448.99K
- C. Jeffrey Dekker
- Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Robert E. Conway
- Chairman of the Board
- 101.34K
- Jacob Ma-Weaver
- Director
- 53.89K
- Dr. Linda S. Grais, J.D.,M.D.
- Independent Director
- 68.84K
- Dr. Anders D. Hove,M.D.
- Independent Director
- 56.34K
- James Flynn
- Independent Director
- 24.68K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg